Clinical Trial Update: A Placebo-Controlled, Randomized, Safety and Efficacy Study to Evaluate the Change in Hemoglobin A1c Levels in Type 2 Diabetic Subjects While Taking Nutralin [Phase 2]

View source ↗

Summary

A Phase 2 placebo-controlled trial evaluating Nutralin for HbA1c change in Type 2 diabetes has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Nutralin

Snippet

Sponsor: Avera McKennan Hospital & University Health Center | Conditions: Diabetes | Phase 2 | Status: WITHDRAWN